<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Connell | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/grassbreath7/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/grassbreath7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Connell.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7023b4de65888cea43b5da910798f9c5</guid>
				<title>Connell posted an update: Long term regular intake of black tea (BT) can lower blood [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41320/</link>
				<pubDate>Sat, 08 Feb 2025 08:05:01 -0800</pubDate>

									<content:encoded><![CDATA[<p>Long term regular intake of black tea (BT) can lower blood pressure, which is probably due to its antioxidant activity and angiotensin converting enzymes (ACE) inhibitory activity. This study achieves a comprehensive understanding of the relationship between bioactive compounds of BT and its ACE inhibitory activity and antioxidant activity.&hellip;<span class="activity-read-more" id="activity-read-more-41320"><a href="http://www.nationalboardinstitute.com/activity/p/41320/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b333204aa00a7775b5c2cb7bb1a7a0ea</guid>
				<title>Connell posted an update: Hence, more detailed reports remain necessary to improve [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39440/</link>
				<pubDate>Thu, 06 Feb 2025 08:01:29 -0800</pubDate>

									<content:encoded><![CDATA[<p>Hence, more detailed reports remain necessary to improve insight in MODY12 pathophysiology and outcome. In this article current data regarding therapeutic management are provided, and key points to consider for the individual patient affected by MODY12 are presented.</p>
<p> Current scientific guidelines recommend collecting placental specimens within&hellip;<span class="activity-read-more" id="activity-read-more-39440"><a href="http://www.nationalboardinstitute.com/activity/p/39440/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1615f8ce6afff04f8961e56f71d3182c</guid>
				<title>Connell posted an update: At the moment, the results obtained by preclinical [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30991/</link>
				<pubDate>Tue, 28 Jan 2025 16:01:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>At the moment, the results obtained by preclinical experimental and observational clinical studies suggest that the risks of the maternal COVID-19 outweigh the undocumented and hypothetical risks of the COVID-19 vaccines in pregnancy. Also, until two viral vector COVID-19 vaccines were associated with very rare thromboembolic events, all guidance&hellip;<span class="activity-read-more" id="activity-read-more-30991"><a href="http://www.nationalboardinstitute.com/activity/p/30991/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">091a18170e1698159ef3d54d98600f7a</guid>
				<title>Connell became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30949/</link>
				<pubDate>Tue, 28 Jan 2025 15:58:32 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>